Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    6 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:11:47.000Z thumbnail image
  6. Check
    13 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification related to the safety observation of velaglucerase alfa in patients with type 1 Gaucher disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:03.000Z thumbnail image
  7. Check
    28 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for patients with type 1 Gaucher disease, specifying inclusion and exclusion criteria, whereas previously it stated 'No information provided'. This change provides specific requirements for patient participation in the study, such as age, health conditions, and prior treatments.
    Difference
    14%
    Check dated 2024-05-22T20:57:02.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:59:52.000Z thumbnail image

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.